A new market study, titled “Cancer Stem Cells: Technologies and Global Markets”, has been featured on WiseGuyReports.
Cancer stem cells (CSCs) have properties similar to normal stem cells and have the ability to produce all cell types found in a single type of cancer. These cells are tumorigenic and have the ability to generate tumors through self-renewal and differentiation. CSCs are believed to occur in tumors as a distinct population and produce new tumors by relapse and metastasis. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease. Cancer stem cells are rare forms of immortal cells that occur in a tumor and give rise to many cell types that constitute the tumor. These cells have been found in a range of human tumors and are a potential approach as targets for cancer treatment. Most anticancer therapies inhibit cancer cell growth by causing cancer cells to die. Although these treatments appear to be successful, the disease reoccurs in some cases.
Major factors contributing to the market growth are a rise in the incidence and mortality rate of cancer worldwide and increased R&D activities associated with the development of these therapies. The rise in incidence of cancer globally has increased the requirement of a reliable and effective therapy that will completely eliminate the cancer cells in the body and reduce the risk of relapse or metastasis in the patient. Thus, there is a rise in the cancer research activities and rise in funding for the advancement of technology. The rise in R&D activities will help to improve the knowledge of the researchers regarding CSCs and how these can be used as targets to improve the efficiency of conventional cancer therapies. However, ethical issues related to stem cells and high costs related to cancer stem cell therapeutics could hamper the market growth. Successful implementation of CSCs therapeutics in animal models during preclinical trials will help to open new avenues for the market growth.
The cancer stem cells market is segmented based on geographic region and cancer type, namely, lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, prostate cancer, brain cancer, bone cancer, and other types of cancer. The leukemia segment is the largest contributor towards the market growth due to the introduction of CSC therapy that could be used for the treatment of leukemia. However, brain cancer is expected to be the fastest growing segment.
This research report presents an in-depth analysis of the global cancer stem cells market by cancer type and geographic markets. The report includes key inhibitors that affect various factors that help in growth of cancer stem cells. The report discusses the role of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global cancer stem cells market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe, and China.
The cancer stem cells market is mainly segmented into two major components: cancer type and geography. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, prostate cancer, brain cancer, bone cancer, and other types of cancer. The market is segmented by geography into the North America, Europe, Asia-Pacific, and ROW.MBA in marketing.
– 27 data tables and 25 additional tables
– An overview of the global market for cancer stem cells and related technologies
– Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
– Segmentation of the market by type and by region
– Discussion of market dynamics, including drivers, restraints, and opportunities
– Insight into the competitive landscape, including strategies, acquisitions, agreements, and new product launches
– Profiles of suppliers of cancer stem cells and analyses based on market share, cancer type, and region
Boehringer Ingelheim International GmbH
CIPLA USA INC.
Daiichi-sankyo Co. Ltd
DR. REDDY’S LABORATORIES LTD.
ELI LILLY AND CO.
F. Hoffmann-La Roche AG
GILEAD SCIENCES INC.
GLENMARK PHARMACEUTICALS LIMITED
Janssen Global Services Llc
Kowa Pharmaceuticals America Inc.
LUPIN PHARMACEUTICALS INC.
MERCK & CO. INC.
NOVARTIS HOLDING AG
Sanofi Genzyme Corp.
SUN PHARMACEUTICAL INDUSTRIES LTD.
Takeda Pharmaceuticals Co.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VALEANT PHARMACEUTICALS INTERNATIONAL INC.
Table of Contents
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Breakdown by Technology Type and Region
Chapter 5 Market Breakdown by Application
Chapter 7 Patent Review/ New Developments
Chapter 8 Analysis of Market Opportunities
Chapter 9 Company Profiles
Chapter 10 Appendix: Abbreviations
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)